Ellington Management Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-1,400
Closed -$213K 751
2019
Q2
$213K Buy
+1,400
New +$213K 0.04% 453
2018
Q3
Sell
-3,100
Closed -$410K 653
2018
Q2
$410K Buy
+3,100
New +$410K 0.03% 202
2016
Q4
Sell
-14,100
Closed -$866K 773
2016
Q3
$866K Buy
+14,100
New +$866K 0.24% 93